Close Menu

The Daily Scan recently brought you the blogosphere's reaction to a new website called The Third Reviewer, which allows members of the scientific community to comment — anonymously, if they wish — on published scientific literature. DrugMonkey was among the bloggers who thought it was a great idea because anonymous commenting could allow researchers to be honest about the work of others without fearing they'd be attacked.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.